Worked with C-suite and an accounting firm to conduct an economic analysis, structure, and implement intercompany payments and agreements in preparation for an IPO of an innovative biotech incubator. The analysis included valuation of a unique biotech development and production facility, R&D, engineering and management services.
Highlights from 2025 and looking forward to 2026
In the United States, 2025 brought major activity in high profile transfer pricing disputes and reaffirmed how closely transfer pricing, tariffs, and customs...